Evidence map›Paper›PMID 28903419›Full record

ArticleOncotarget2017

Development of zebrafish medulloblastoma-like PNET model by TALEN-mediated somatic gene inactivation.

Jaegal Shim, Jung-Hwa Choi, Moon-Hak Park, Hyena Kim, Jong Hwan Kim, Seon-Young Kim, Dongwan Hong, Sunshin Kim, Ji Eun Lee, Cheol-Hee Kim and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Small Fish, Big Answers: Zebrafish and the Molecular Drivers of Metastasis.International journal of molecular sciences · 2025
    Review
  3. Medulloblastoma: biology and immunotherapy.Frontiers in immunology · 2025
    Review
  4. Article
  5. Zebrafish Models of Paediatric Brain Tumours.International journal of molecular sciences · 2022
    Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Jaegal Shim *Comparative Biomedicine Research Branch, Research Institute, National Cancer Center, Goyang, Republic of Korea.
Jung-Hwa Choi *Department of Biology, Chungnam National University, Daejeon, Republic of Korea.
Moon-Hak ParkTumor Microenviroment Research Branch, Research Institute, National Cancer Center, Goyang, Republic of Korea.
Hyena KimTumor Microenviroment Research Branch, Research Institute, National Cancer Center, Goyang, Republic of Korea.
Jong Hwan KimGenome Structure Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
Seon-Young KimGenome Structure Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
Dongwan HongClinical Genomic Analysis Branch, Research Institute, National Cancer Center, Goyang, Republic of Korea.
Sunshin KimPrecision Medicine Branch, Research Institute, National Cancer Center, Goyang, Republic of Korea.
Ji Eun LeeDepartment of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Gangnam-gu, Seoul, Republic of Korea.
Cheol-Hee KimDepartment of Biology, Chungnam National University, Daejeon, Republic of Korea.
Jeong-Soo LeeDisease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
Young-Ki BaeComparative Biomedicine Research Branch, Research Institute, National Cancer Center, Goyang, Republic of Korea.
National Cancer Center · KRKorea Research Institute of Bioscience and Biotechnology · KRChungnam National University · KRConvergence Research Center for Diagnosis Treatment and Care System of Dementia · KRKorea University of Science and Technology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetically engineered animal tumor models have traditionally been generated by the gain of single or multiple oncogenes or the loss of tumor suppressor genes; however, the development of live animal models has been difficult given that cancer phenotypes are generally induced by somatic mutation rather than by germline genetic inactivation. In this study, we developed somatically mutated tumor models using TALEN-mediated somatic gene inactivation of

Indexed as

medulloblastomaMPNSTPNETsomatic inactivationTALEN

Identifiers

PMID28903419
PMCPMC5589658
OpenAlexW2736539738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.